Global IVD distributors are no longer only looking for finished products. Many are building differentiated portfolios through OEM and ODM cooperation. In point-of-care testing, this approach allows distributors to combine local market knowledge with manufacturer capabilities in assay development, instrument design, packaging, documentation, and regulatory support.
Why OEM and ODM matter in POCT
POCT markets are highly regional. Customer preferences, disease prevalence, reimbursement conditions, language requirements, regulatory pathways, and distribution channels vary widely between countries. A standard product may not fully match local needs. OEM and ODM development gives distributors more flexibility in product positioning, branding, test menu selection, and workflow design.
For example, a distributor may need a TRF immunoassay analyzer with a localized interface, a microfluidic PCR system for a specific infectious disease panel, or lateral flow strips with customized packaging and instructions. OEM/ODM cooperation can create a stronger market fit than simple product resale.
Choosing the right technology platform
A competitive POCT portfolio often includes multiple technology layers. Lateral flow tests are useful for rapid qualitative screening. TRF immunoassay analyzers support quantitative biomarker detection. Microfluidic PCR systems provide molecular sensitivity for infectious disease and genetic targets. CRISPR-based test strips can offer sequence-specific molecular detection in simplified formats.
The best platform depends on clinical need, target users, price range, required sensitivity, infrastructure, and regulatory expectations. Distributors should evaluate not only product performance but also manufacturing capacity, quality system maturity, documentation support, and after-sales responsiveness.
Key questions before starting an OEM/ODM project
Before starting a project, distributors should define target markets, intended users, sample types, target analytes, expected performance, packaging requirements, labeling language, registration pathway, annual demand, and launch timeline. Clear requirements reduce development risk and help the manufacturer design a realistic project plan.
It is also important to discuss ownership of documentation, validation responsibilities, technical support, change notification, quality agreement terms, complaint handling, and post-market cooperation. These details are essential for sustainable international business.
Building long-term value
A strong OEM/ODM partnership can help distributors move from price competition to portfolio differentiation. Instead of selling the same products as competitors, distributors can develop customized POCT solutions for hospitals, clinics, laboratories, veterinary users, or public health programs.
DueBio works with international partners on POCT and IVD OEM/ODM projects, including TRF immunoassay analyzers, microfluidic PCR systems, Cas12/Cas13 test strips, and rapid test strip development.